AVBP: Arrivent Biopharma Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Arrivent Biopharma Inc (AVBP).
$897.69M Market Cap.
AVBP Market Cap. (MRY)
AVBP Shares Outstanding (MRY)
AVBP Assets (MRY)
Total Assets
$274.94M
Total Liabilities
$17.29M
Total Investments
$192.25M
AVBP Income (MRY)
Revenue
$0
Net Income
-$80.49M
Operating Expense
$94.31M
AVBP Cash Flow (MRY)
CF Operations
-$70.21M
CF Investing
-$192.47M
CF Financing
$186.58M
AVBP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Total Assets | $274,942,000 (68.57%) | $163,098,000 (-10.79%) | $182,833,000 |
Assets Current | $226,979,000 (41.89%) | $159,968,000 (-12.40%) | $182,622,000 |
Assets Non-Current | $47,963,000 (1432.36%) | $3,130,000 (1383.41%) | $211,000 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | $257,654,000 (268.19%) | -$153,193,000 (-80.00%) | -$85,109,000 |
Property Plant & Equipment Net | $154,000 (-47.08%) | $291,000 (109.35%) | $139,000 |
Cash & Equivalents | $74,293,000 (-50.60%) | $150,389,000 (-7.95%) | $163,372,000 |
Accumulated Other Comprehensive Income | -$211,000 (0%) | $0 (0%) | $0 |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 |
Total Investments | $192,253,000 (0%) | $0 (0%) | $0 |
Investments Current | $144,570,000 (0%) | $0 (0%) | $0 |
Investments Non-Current | $47,683,000 (0%) | $0 (0%) | $0 |
Inventory | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $3,782,000 (-16.55%) | $4,532,000 (46.48%) | $3,094,000 |
Accumulated Retained Earnings (Deficit) | -$238,333,000 (-50.99%) | -$157,845,000 (-78.33%) | -$88,512,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 |
Total Debt | $176,000 (-44.48%) | $317,000 (128.06%) | $139,000 |
Debt Current | $162,000 (15.71%) | $140,000 (9.38%) | $128,000 |
Debt Non-Current | $14,000 (-92.09%) | $177,000 (1509.09%) | $11,000 |
Total Liabilities | $17,288,000 (46.50%) | $11,801,000 (40.97%) | $8,371,000 |
Liabilities Current | $17,274,000 (48.61%) | $11,624,000 (39.04%) | $8,360,000 |
Liabilities Non-Current | $14,000 (-92.09%) | $177,000 (1509.09%) | $11,000 |
AVBP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $15,304,000 (57.68%) | $9,706,000 (49.95%) | $6,473,000 |
Research & Development Expense | $79,004,000 (21.76%) | $64,884,000 (113.20%) | $30,433,000 |
Operating Expenses | $94,308,000 (26.44%) | $74,590,000 (102.11%) | $36,906,000 |
Interest Expense | $0 (0%) | $0 (0%) | $0 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$80,488,000 (-16.09%) | -$69,333,000 (-87.86%) | -$36,906,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 |
Net Income | -$80,488,000 (-16.09%) | -$69,333,000 (-87.86%) | -$36,906,000 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$80,488,000 (-16.09%) | -$69,333,000 (-87.86%) | -$36,906,000 |
Weighted Average Shares | $31,469,328 (1369.88%) | $2,140,951 (67.64%) | $1,277,079 |
Weighted Average Shares Diluted | $31,469,328 (1369.88%) | $2,140,951 (67.64%) | $1,277,079 |
Earning Before Interest & Taxes (EBIT) | -$80,488,000 (-16.09%) | -$69,333,000 (-87.86%) | -$36,906,000 |
Gross Profit | $0 (0%) | $0 (0%) | $0 |
Operating Income | -$94,308,000 (-26.44%) | -$74,590,000 (-102.11%) | -$36,906,000 |
AVBP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Net Cash Flow from Investing | -$192,465,000 (0%) | $0 (0%) | $0 |
Net Cash Flow from Financing | $186,581,000 (335.34%) | $42,859,000 (-74.75%) | $169,723,000 |
Net Cash Flow from Operations | -$70,212,000 (-25.73%) | -$55,842,000 (-27.99%) | -$43,631,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$76,096,000 (-486.12%) | -$12,983,000 (-110.30%) | $126,092,000 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | -$192,465,000 (0%) | $0 (0%) | $0 |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 |
Issuance (Purchase) of Equity Shares | $186,581,000 (52606.50%) | $354,000 (1982.35%) | $17,000 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $3,208,000 (258.44%) | $895,000 (111.08%) | $424,000 |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 |
AVBP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Gross Margin | - | - | - |
Profit Margin | - | - | - |
EBITDA Margin | - | - | - |
Return on Average Equity (ROAE) | -28.00% (-148.11%) | 58.20% (-65.40%) | 168.20% |
Return on Average Assets (ROAA) | -26.70% (33.42%) | -40.10% (-22.63%) | -32.70% |
Return on Sales (ROS) | - | - | - |
Return on Invested Capital (ROIC) | -181.30% (83.47%) | -1096.90% (-125.61%) | -486.20% |
Dividend Yield | 0% | - | - |
Price to Earnings Ratio (P/E) | -10.41 | - | - |
Price to Sales Ratio (P/S) | - | - | - |
Price to Book Ratio (P/B) | 3.48 | - | - |
Debt to Equity Ratio (D/E) | 0.07 (187.01%) | -0.08 (21.43%) | -0.1 |
Earnings Per Share (EPS) | -2.56 (92.09%) | -32.38 (-12.04%) | -28.9 |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 |
Free Cash Flow Per Share (FCFPS) | -2.23 (91.45%) | -26.08 (23.66%) | -34.16 |
Book Value Per Share (BVPS) | 8.19 (111.44%) | -71.55 (-7.37%) | -66.64 |
Tangible Assets Book Value Per Share (TABVPS) | 8.74 (-88.53%) | 76.18 (-46.79%) | 143.16 |
Enterprise Value Over EBIT (EV/EBIT) | -8 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -7.64 | - | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 |
Current Ratio | 13.14 (-4.52%) | 13.76 (-37.00%) | 21.84 |
Dividends | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$70,212,000 (-25.73%) | -$55,842,000 (-27.99%) | -$43,631,000 |
Enterprise Value (EV) | $615,050,369 | - | - |
Earnings Before Tax (EBT) | -$80,488,000 (-16.09%) | -$69,333,000 (-87.86%) | -$36,906,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$80,488,000 (-16.09%) | -$69,333,000 (-87.86%) | -$36,906,000 |
Invested Capital | $183,551,000 (12992.08%) | $1,402,000 (-87.53%) | $11,240,000 |
Working Capital | $209,705,000 (41.36%) | $148,344,000 (-14.87%) | $174,262,000 |
Tangible Asset Value | $274,942,000 (68.57%) | $163,098,000 (-10.79%) | $182,833,000 |
Market Capitalization | $897,692,369 | - | - |
Average Equity | $287,382,250 (341.19%) | -$119,151,000 (-442.98%) | -$21,944,000 |
Average Assets | $301,086,500 (74.07%) | $172,965,500 (53.15%) | $112,936,000 |
Invested Capital Average | $44,387,250 (602.22%) | $6,321,000 (-16.72%) | $7,590,500 |
Shares | 33,697,161 (51.55%) | 22,234,435 (0.00%) | 22,234,435 |
